Berkeley Brochures
-
Opto® Memory B Discovery Rabbit Workflow
12/2/2022
Learn about an Optofluidic System that enables rapid selection of lead molecules by function-forward screening of B cells from immunized animals in under 1 week.
-
Opto™ Plasma B Discovery 4.0 Workflow
9/28/2022
The Opto Plasma B Discovery 4.0 workflow on the Beacon® optofluidic system enables functional profiling of the B cell repertoire to rapidly advance lead molecules against difficult targets.
-
Recover Clones With 99% Monoclonality Assurance And Reduce Timelines
8/25/2022
Explore how this optofluidic system offers an integrated end-to-end automated workflow for rapid cloning and selection in mammalian cell line development.
-
T Cell Biology Reimagined
4/25/2022
Our T cell workflow allows you to investigate complex cell-cell interactions. Our portfolio of capabilities includes assays to study polyfunctionality, cytotoxicity and the ability to directly link phenotype to gene expression.
-
Maximize Functional Characterization Of Your Precious T Cell Samples With The Opto™ Cell Therapy Development Workflow
9/10/2021
The Opto™ Cell Therapy Development worfklow accelerates the creation of better therapeutics by enabling multiple functional assays to be performed simultaneously on 1000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link behavior to gene expression.
-
Get To Market Faster With The Opto™ CLD Workflow On The Beacon® System
8/25/2021
Find out how the Opto™ Cell Line Development workflow sets a new standard for quality, capacity, and speed in cell line development to let BioPharma get more molecules to the clinic faster.
-
Beacon® Optofluidic System Brochure
8/22/2021
Identifying T cell functional signatures is a long, laborious, and complex process that requires you to draw conclusions from surrogate measurements collected on multiple platforms. The Lightning system changes this by allowing you to directly visualize the phenotype and function of 1000s of individual cells in just days and recover cells of interest alive.
-
Increase CDMO Revenue With The Opto™ CLD Workflow On The Beacon® System
8/20/2021
Find out how the Opto™ Cell Line Development workflow sets a new standard for quality, capacity, and speed in cell line development and allows CDMOs to scale operations and drive new business.
-
Antigen Presentation Bead Kit
3/5/2021
Antigen-specific T cells can be selectively expanded using the Opto™ Antigen Presenting Bead kit upstream of the Opto™ Cell Therapy Development workflow, enabling you to directly link peptide binding and recognition to antigen specific effector function.
-
Opto™ Cell Therapy Development Workflow: Single Cell Cytokine Assay
1/22/2021
Cytokine assays in the Opto™ Cell Therapy Development workflow allow simultaneous functional interrogation of thousands of individual T cells as they interact with antigen-presenting cells, granting insight into the heterogenous mechanisms that regulate cytokine secretion. The automated assays also allow live recovery of individual clones for downstream analysis. Cytokine assays and cell surface markers can be customized.